Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VELAGLUCERASE ALFA vs VEMURAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VELAGLUCERASE ALFA vs VEMURAFENIB: Safety Overview

Metric VELAGLUCERASE ALFA VEMURAFENIB
Total FAERS Reports 1,745 8,562
Deaths Reported 229 1,040
Death Rate 13.1% 12.1%
Hospitalizations 771 2,368
Average Patient Age 44.7 yrs 58.1 yrs
% Female Patients 51.6% 45.7%
FDA Approval Date N/A Aug 17, 2011
Manufacturer Takeda Pharmaceuticals America, Inc. Genentech, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription